2.84CNY
2.15 BCNY
49.58 BCNY
441.90 M
About CHINA NATIONAL MEDICINES CORPORATION LTD.
Sector
CEO
Guo Tao Tian
Headquarters
Beijing
Website
Founded
1999
ISIN
CNE000001D56
FIGI
BBG000PKBGL6
China National Medicines Co., Ltd. engages in the manufacturing and distribution of pharmaceuticals. It offers logistic services, chemical preparations, raw materials, antibiotics, biochemical and narcotic drugs, Internet information services, prepackaged foods and medical equipment. The company was founded on December 21, 1999 and headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 600511 is 35.38 CNY — it has decreased by 0.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange CHINA NATIONAL MEDICINES CORPORATION LTD. stocks are traded under the ticker 600511.
CHINA NATIONAL MEDICINES CORPORATION LTD. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for CHINA NATIONAL MEDICINES CORPORATION LTD. has a max estimate of 47.60 CNY and a min estimate of 37.00 CNY.
Yes, you can track CHINA NATIONAL MEDICINES CORPORATION LTD. financials in yearly and quarterly reports right on TradingView.
600511 stock has risen by 7.18% compared to the previous week, the month change is a 15.81% rise, over the last year CHINA NATIONAL MEDICINES CORPORATION LTD. has showed a 10.34% decrease.
Like other stocks, 600511 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA NATIONAL MEDICINES CORPORATION LTD. stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHINA NATIONAL MEDICINES CORPORATION LTD. EBITDA is 2.58 B CNY, and current EBITDA margin is 5.19%. See more stats in CHINA NATIONAL MEDICINES CORPORATION LTD. financial statements.